Dr. Neha Pagidapati from Duke University discusses GLP-1 receptor agonists with CardioNerds. They cover clinical indications, metabolic benefits, and limitations of these therapies. Topics include medication titration, side effects management, and challenges in obtaining coverage for anti-obesity medications. The podcast also explores disparities in drug access, risks of counterfeit drugs, and the importance of perseverance in utilizing GLP1 agonists for cardiovascular health.